Stereotaxis STXS
NYSE STXS
$0.83 -0.02 (-2.35%)
At close: Nov 13, 2026 · 4:00 PM EST

Stereotaxis (STXS) Long-Term Deferred Tax (2021 - 2023)

Updated

Stereotaxis' Long-Term Deferred Tax was $36.3 million in Q4 2023, up 8.4% from $33.48 million a year earlier.

Analysis

Stereotaxis (STXS) Long-Term Deferred Tax (2021 - 2023) Analysis & Trends

  • In earlier years, Long-Term Deferred Tax was $33.48 million in FY2022 (+6.3%) and $31.49 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Stereotaxis 83.17 Mn 83.17 Mn 3.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 36.30 Mn
Dec 31, 2022 33.48 Mn
Dec 31, 2021 31.49 Mn
API Access

Stereotaxis Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=STXS&period=max&api_key=YOUR_API_KEY